• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Precision Therapeutics Inc.

CEO invests $1.37M in Precision Therapeutics

January 18, 2019 By Nancy Crotti

Precision Therapeutics (NSDQ:AIPT) CEO Carl Schwartz recently boosted his stake in the company by $1.37 million, including a $950,000 loan and the $50,000 purchase of 78,125 shares of the company’s common stock, representing a price of $0.64 per share. As part of the investment, detailed this week in an SEC filing, Schwartz also received additional […]

Filed Under: Business/Financial News, Funding Roundup, News Well Tagged With: Helomics, Precision Therapeutics Inc.

Precision Therapeutics finalizes Helomics buy, completes pivot to personalized medicine

June 29, 2018 By Fink Densford

Precision Therapeutics (NSDQ:AIPT) said yesterday it inked a definitive merger agreement with Helomics, completing the company’s plan to pivot towards artificial-intelligence powered personalized medicine. Minneapolis-based Precision Therapeutics inked a deal to acquire the remaining 75% equity stake in Helomics in April, after having purchased preferred stock in the company convertible into a 20% stake in January and converting […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Oncology Tagged With: Precision Therapeutics Inc.

Precision Therapeutics to acquire Helomics

April 23, 2018 By Fink Densford

Precision Therapeutics (NSDQ:AIPT) said today it inked a letter of intent to acquire the remaining equity in Helomics, making it a wholly owned subsidiary. Minneapolis, Minn.-based Precision Therapeutics, which currently owns 25% of Helomics, said that it will acquire the remaining 75% equity stake in the company. Precision Therapeutics said it is hopeful that a new […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Oncology Tagged With: Helomics, Precision Therapeutics Inc.

Precision Therapeutics takes Helomics stake to 25%

March 15, 2018 By Fink Densford

Precision Therapeutics (NSDQ:AIPT), formerly known as Skyline Medical, said today it converted a previous $500,000 loan with Helomics into a 5% equity stake, bringing the company’s ownership in Helomics up to 25%. In January, Minneapolis, Minn.-based Precision Therapeutics purchased preferred stock in Pittsburgh, Penn.-based Helomics convertible into a 20% stake. Helomics developed and maintains the […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Oncology Tagged With: Precision Therapeutics Inc.

Invuity prez & CEO Sawyer steps down, Flora in as interim | Personnel Moves – March 13, 2018

March 13, 2018 By Fink Densford

Invuity (NSDQ:IVTY) said late last week that its president and chief executive officer Philip Sawyer has resigned and will be replaced by board member Scott Flora on an interim basis. Flora has served as a member of the board since last November, and has held positions as prez, CEO and director of Omniguide. He has also held […]

Filed Under: Business/Financial News Tagged With: Boston Scientific, CHF Solutions Inc., Endologix, endospan, Frequency Therapeutics, Intuitive Surgical, Invuity, Johnson and Johnson, Medtronic, milestonescientific, OmniGuide, Physeon, Precision Therapeutics Inc., Raumedic, Tearlab Corp.

Precision Therapeutics to launch new genomics product in 2011

June 11, 2010 By MedCity News Leave a Comment

MedCity News logo

By Brandon Glenn

Fresh off a $34 million Series D fundraise, Precision Therapeutics Inc. is planning to launch a “genomics” product sometime in 2011.

Filed Under: Business/Financial News, Diagnostics, News Well, Oncology Tagged With: Precision Therapeutics Inc.

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy